Bafna Pharmaceuticals Ltd - BAFNA PHARMA. Share Price

Sector: Pharmaceuticals | ISIN: INE878I01022
₹ 124.45 (4.98%) icon5 Jun, 2023, 2:31:08 PM
Open
₹ 123.80
Prev. Close
₹ 118.55
Turnover(lac)
₹ 11.03
Day's High
₹ 124.45
Day's Low
₹ 121.00
52 Wk High
₹ 128.10
52 Wk Low
₹ 77.05
Book Value
₹ 31.37
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 294.40
P/E
26.21
EPS
4.79
Div. Yield
0.00

Bafna Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 6/5/2023 2:31:08 PM

    ₹ 124.45 5.90 4.98
  • Open
  • ₹ 123.8
  • Prev. Close
  • ₹ 118.55
  • Turnover(Lac.)
  • ₹ 11
  • Day's High
  • ₹ 124.45
  • Day's Low
  • ₹ 121
  • 52 Week's High
  • ₹ 128.1
  • 52 Week's Low
  • ₹ 77.05
  • Book Value
  • ₹ 31.37
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 294.4
  • P/E
  • 26.21
  • EPS
  • 4.79
  • Divi. Yield
  • 0

Bafna Pharmaceuticals Ltd Corporate Actions

17 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2023

12:00 AM

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

04 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Aug , 2022

12:00 AM

26 May , 2022

12:00 AM

AGM

Announcement date: 26 May , 2022

View Details

05 Jul , 2022

12:00 AM

BookCloser

View Details

Bafna Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
10 June , 2023 | 09:46 AM

PROMOTER - TOTAL90.00%

Indian: 90.00%

Foreign: 0%

NON-PROMOTER - TOTAL 10.00%

Institutions: 0.00%

Non-Institutions: 10.00%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Bafna Pharmaceuticals Ltd News and Update

Article Image
  • 23 hours ago |
  • 5:54 PM

The company will use proceeds from the fresh issue towards working capital requirements and general corporate purposes.

Image not found
Article Image
ad IconAd Image

Bafna Pharmaceuticals Ltd FINANCIALS

Bafna Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Bafna Pharmaceuticals Ltd

  • Babulal Kamlesh Kumar
  • Non-Exec. & Independent Dir.
  • Shanmugam Hemalatha
  • Chairperson / Executive Direct
  • Akilapriya Chandrashekar Raju
  • Non-Exec & Non-Independent Dir
  • Palamadai Krishnan Sundaresan
  • Non-Exec. & Independent Dir.
  • Ravichandran Chitra
  • Non-Exec. & Independent Dir.
  • Atul Sachdeva
  • Non-Exec & Non-Independent Dir
  • Vishnu Vasudeva Kuppa
  • Company Sec. & Compli. Officer

Summary

Bafna was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a. Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. During the year 1995, Bafna Pharmaceuticals Limited was incorporated and it acquired the entire business of the proprietary concern. During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products. During 2006, Bafna has set up a 100% EOU unit at Madhavaram for the production of tablets and capsule with a capacity of 6973.20 lacs and 2462.40 lacs. This facility has been set up as per revised Schedule M under the Drugs and Cosmetics Act, 1947. The unit has been WHO GMP certified and also ISO 9000 certified. The manufactured products in this factory catered to the markets of Srilanka, Ghana and Ukraine.Bafna was carrying on contract manufacturing for M/s Croslands Pvt. Ltd, a Mumbai based Pharmaceutical Company during the period 1994 to 2000. The companys first product was registered in Srilanka in 1995 and the company made its first export during the same... Read More


Reports by Bafna Pharmaceuticals Ltd


Reports by Bafna Pharmaceuticals Ltd